Viewpoints: Restricting Kids’ Access To Vaccines Is A Human Rights Violation; Pazdur Is Great Pick To Lead CDER
Editorial writers examine these public health issues.
The independent source for health policy research, polling, and news.
1,761-1,780 of 112,954 results
Editorial writers examine these public health issues.
A new report points to 27 completed or planned labor and delivery unit closures this year. Other industry news is on Genesis HealthCare, the fight between Blue Cross Blue Shield of Massachusetts and the UMass Memorial Health system, pediatric ER care, and more.
Pazdur will head the FDA's Center for Drug Evaluation and Research, replacing George Tidmarsh. Other pharma news is on telehealth prescriptions for certain controlled substances, health information privacy related to wearable devices and mobile health apps, and more.
The FDA issued the announcement Monday. Commissioner Marty Makary said the warnings were based on outdated science. Scroll down to our Editorials and Opinions section to read the story.
The Supreme Court's emergency ruling will expire by midnight Thursday, giving the House and President Trump just days to approve and sign a measure that would fund the government.
Republicans are floating ideas for discussion after the government reopens. One idea from Senate Majority Leader John Thune, R-S.D., would extend the soon-to-expire Obamacare subsidies in exchange for stricter abortion restrictions on insurance plans. Another idea from President Donald Trump would give federal health care funds directly to individuals instead of through insurers. Policy experts say Obamacare would collapse under that plan.
Today's early morning highlights from the major news organizations.
Opinion writers discuss these public health topics.
The Task Force on Responsible Use of Natural Psychedelic Substances submitted its report on the benefits of easing restrictions on psilocybin, mescaline, and dimethyltryptamine, three natural psychedelics. Also in the news: Colorado, Ohio, Connecticut, North Carolina, Texas, California, and Louisiana.
Merck's new pill, enlicitide, and Amgen's longtime Repatha shot are showing heart attack risk-lowering potential, and researchers have made progress on the gene-editing front.
Researchers also found higher risks of chronic rhinitis, chronic rhinosinusitis, and nasal polyposis. Also, ByHeart baby formula has been recalled due to a multistate outbreak of infant botulism. Plus, research shows 1 in 27 women are informally sharing breast milk.
There's no specific plan for the payments, which Congress would likely need to approve. Meanwhile, the Supreme Court is hearing arguments about whether Trump overstepped his authority in levying tariffs without congressional support. Plus: Would 50-year mortgages help the housing crisis?
On Sunday night, an appeals court denied President Donald Trump's efforts to halt the release of full funding for November's payments. Trump also threatened Friday to penalize states that paid full benefits and ordered them to claw back the money. It's unclear if that demand still stands.
Eight senators voted with the Democratic caucus to advance a compromise measure to fund the government through the end of January. SNAP benefits would resume, but the extension of health care tax credits is not included. Plus, President Trump renews call to repeal Obamacare.
Today's early morning highlights from the major news organizations.
Each week, KFF Health News finds longer stories for you to enjoy. Today's selections are on peanut allergies, nutrition, SAD, ELISA testing, and more.
Editorial writers examine these public health issues.
Instagram, Facebook, TikTok, YouTube, and Snapchat's parent companies will be forced to face trial in the claim that they designed social media platforms to addict youths. Trials are set to start in January, after Los Angeles Superior Court Judge Carolyn Kuhl ruled against the companies this week in their last chance to avoid trial.
In the Thursday filing, Texas Attorney General Ken Paxton accused the makers of Tylenol of false advertising because the painkiller is promoted as safe to use during pregnancy.
The Supreme Court let stand a Trump administration policy that bars people from updating their gender markers. One ACLU director quickly denounced the decision, calling it an "attempt to dehumanize, humiliate, and endanger transgender, nonbinary, and intersex Americans."
© 2026 KFF